{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T21:23:49Z","timestamp":1746653029546,"version":"3.30.1"},"reference-count":10,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1609.091837","type":"journal-article","created":{"date-parts":[[2010,8,23]],"date-time":"2010-08-23T14:55:28Z","timestamp":1282575328000},"page":"1500-1501","source":"Crossref","is-referenced-by-count":8,"title":["Hospital Discharge Data for Guillain-Barr\u00e9 Syndrome and Influenza A (H1N1) Vaccine Adverse Events"],"prefix":"10.3201","volume":"16","author":[{"given":"Timothy F.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcy","family":"McMillian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Effie","family":"Boothe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Amanda","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","published-online":{"date-parts":[[2010,9]]},"reference":[{"key":"key-10.3201\/eid1609.091837-201208241249-R1","first-page":"1","article-title":"Safety of influenza A (H1N1) 2009 monovalent vaccines\u2014United States, October 1\u2013November 24, 2009.","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1609.091837-201208241249-R2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1586\/14760584.7.1.75","article-title":"Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience.","volume":"7","author":"Iskander","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"key-10.3201\/eid1609.091837-201208241249-R3","first-page":"265","article-title":"Monitoring vaccine safety during an influenza pandemic.","volume":"78","author":"Iskander","year":"2005","journal-title":"Yale J Biol Med"},{"key":"key-10.3201\/eid1609.091837-201208241249-R4","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain-Barr\u00e9 syndrome following influenza vaccination.","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"key":"key-10.3201\/eid1609.091837-201208241249-R5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome.","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol"},{"key":"key-10.3201\/eid1609.091837-201208241249-R6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain-Barr\u00e9 syndrome worldwide. A systematic literature review.","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"key":"key-10.3201\/eid1609.091837-201208241249-R7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3414\/ME0500","article-title":"Predictive value of ICD-9-CM codes used in vaccine safety research.","volume":"47","author":"Mullooly","year":"2008","journal-title":"Methods Inf Med"},{"key":"key-10.3201\/eid1609.091837-201208241249-R8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/archpedi.158.11.1031","article-title":"Safety of the trivalent inactivated influenza vaccine among children: a population-based study.","volume":"158","author":"France","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key-10.3201\/eid1609.091837-201208241249-R9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s100720200036","article-title":"Validity of hospital discharge diagnoses for public health surveillance of the Guillain-Barr\u00e9 syndrome.","volume":"23","author":"Bogliun","year":"2002","journal-title":"Neurol Sci"},{"key":"key-10.3201\/eid1609.091837-201208241249-R10","unstructured":"Sejvar J, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter N, Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definition and guidelines for collection, analysis and presentation of immunization safety data. Atlanta: Centers for Disease Control and Prevention; 2009 [cited 2010 Apr 26]. http:\/\/www.brightoncollaboration.org"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/16\/9\/09-1837_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:02:23Z","timestamp":1733284943000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/16\/9\/09-1837_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":10,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2010,9]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1609.091837","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"type":"print","value":"1080-6040"},{"type":"electronic","value":"1080-6059"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}